Cardlytics CDLX
- Market cap
- $10.6M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.1×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $179.3M
- −30% on a year ago
- Net margin
- −55.9%
- Free cash flow yield
- 4.4%
Cardlytics trades at 0.1× sales. Its trailing earnings are negative, so it has no PE. Revenue was $179.3M over the last twelve months, down 30% on a year earlier with a −56% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $79M+9% | $89.2M+8% | $67.6M+5% | $69.6M−9% | $67.1M−15% | $74M−17% | $56.4M−17% | $58M−17% | $52M−22% | $56.1M−24% | $34.3M−39% | $36.9M−37% | |
| R&D | $12.4M−10% | $12.5M−16% | $13M+13% | $13.5M−9% | $13.2M+6% | $9.9M−21% | $10.3M−21% | $9.9M−27% | $8.8M−33% | $8M−20% | $6.4M−37% | $5.5M−44% |
| SG&A | $29.7M−22% | $28M−24% | $28.6M+6% | $30.2M−4% | $25.2M−15% | $25.1M−10% | $23.3M−19% | $21.2M−30% | $18.7M−26% | $17.3M−31% | $15M−36% | $14.5M−32% |
| −$20.7M | −$102.9M−73% | −$22.8M | −$15.8M−35% | −$148.5M+619% | −$8.3M−92% | −$11.1M−51% | −$9.6M−40% | −$68.9M−54% | −$6.1M−27% | −$8.3M−26% | −$5.4M−43% | |
| Interest expense | $915K−3% | $4.7M+400% | $1.7M+81% | $2.4M+318% | $2.4M+162% | −$15.4M | $2.4M+41% | $2.4M+0% | $2.9M+21% | $2.9M | $2.8M+17% | $2.5M+4% |
| Pre-tax income | −$24M | −$100.8M−73% | −$24.3M | −$4.3M−82% | −$145.2M+506% | −$15.6M−85% | −$10.3M−58% | −$6.1M+42% | −$72.7M−50% | −$8.3M−47% | −$13.8M+34% | −$8.7M+43% |
| $0 | $0 | n/a | n/a | n/a | n/a | $0 | $0 | n/a | n/a | $0 | $0 | |
| Net income | −$24M | −$100.8M−73% | −$24.3M | −$4.3M−82% | −$145.2M+506% | −$15.6M−85% | −$13.3M−45% | −$9.3M+118% | −$72.7M−50% | −$8.3M−47% | −$4.5M−66% | −$14.9M+60% |
| −$6.30 | −$25.60−78% | −$5.60 | −$0.90−87% | −$29.00+360% | −$3.10−88% | −$2.00−64% | −$1.15+28% | −$13.60−53% | −$1.50−52% | −$2.50+25% | −$1.50+30% | |
| 3.8M+14% | 3.9M+18% | 4.3M+18% | 4.9M+41% | 5M+32% | 5.1M+29% | 5.2M+20% | 5.3M+8% | 5.3M+7% | 5.4M+7% | 5.5M+6% | 5.8M+9% |
EPS, diluted: 10 periods, Q4 FY17 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 7 periods, Q4 FY17 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY19: share-days: the 12-month average over 365 days less the 9-month over 273, the two on one basis (x1.211). Q4 FY20: a loss quarter: its basic count, share-days: the 12-month average over 366 days less the 9-month over 274, the two on one basis (x1.211).
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Technology nearest Cardlytics' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| CDLXCardlytics | $10.6M | n/m | n/a | 0.1× | −30% | −55.9% | |
| MSGMMotorsport Games | $22.5M | 11.4× | 11.5× | 1.5× | +79% | 16.2% | |
| FIEEFiEE | $26.9M | 9.3× | 102× | n/m | n/m | n/m | |
| NSYSNortech Systems | $29.4M | 27.8× | 13.3× | 0.2× | +6% | 0.8% | |
| IDNIntellicheck | $49.5M | 16.3× | 39.8× | 2.1× | +17% | 13.0% | |
| TZOOTravelzoo | $51.7M | 169× | 20.1× | 0.6× | +5% | 0.5% | |
| OPXSOptex Systems | $66.8M | 17.5× | 15.9× | 1.7× | +1% | 9.8% | |
| WFCFWhere Food Comes From | $74.6M | 53.5× | 42.3× | 3.0× | −2% | 5.8% | |
| RFILR F Industries | $74.8M | 31.4× | 24.8× | 0.9× | +13% | 2.8% | |
| CCLDCareCloud | $75.2M | 25.3× | 37.4× | 0.6× | +15% | 6.2% | |
| FATNFatpipe | $75.3M | 13.7× | 17.2× | 3.7× | +23% | n/m | |
| Peer median | $59.3M | 21.4× | 22.4× | 1.5× | +13% | 6.0% |
More on Cardlytics
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #5of 533Technology stocks with the lowest price to sales ratio
- #3of 114Application software stocks with the lowest price to sales ratio
Its groups
About
- Industry
- Software - Application
- Sector
- Technology
Valuation data, not investment advice. Prices as of .